文献速递淋巴瘤

套细胞淋巴瘤中鉴定的UBR5 HECT结构域突变调控B细胞成熟

UBR5 HECT domain mutations identified in mantle cell lymphoma control maturation of B cells.
PubMed 文献 · Blood · 2020-01-01

研究在约18%的套细胞淋巴瘤(MCL)患者中发现UBR5突变,多数位于HECT结构域;通过构建条件性突变小鼠破坏UBR5的C端HECT结构域,发现其缺失导致脾脏B细胞成熟受阻并上调剪接体相关蛋白,提示UBR5通过稳定剪接体组分调控B细胞成熟,其突变参与MCL转化。

要点

  • 约18%的MCL患者存在UBR5突变,多数位于HECT结构域。
  • UBR5 HECT结构域缺失导致脾脏B细胞成熟受阻。
  • UBR5缺失上调经剪接体介导的mRNA剪接相关蛋白。

核心结论

  • UBR5通过稳定B细胞发育过程中的剪接体组分调控B细胞成熟,UBR5突变可能在MCL转化中起作用。

研究设计与样本

  • 研究采用条件性突变小鼠模型,破坏UBR5的C端HECT结构域,以阐明UBR5在B细胞成熟和活化中的作用。

主要发现

  • 约18%的MCL患者发现UBR5突变,多数突变位于可接受和转移泛素分子至底物的HECT结构域。
  • UBR5 HECT结构域缺失导致脾脏B细胞成熟受阻。
  • UBR5 HECT结构域缺失上调通过剪接体与信使RNA剪接相关的蛋白。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Coordination of a number of molecular mechanisms including transcription, alternative splicing, and class switch recombination are required to facilitate development, activation, and survival of B cells. Disruption of these pathways can result in malignant transformation. Recently, next-generation sequencing has identified a number of novel mutations in mantle cell lymphoma (MCL) patients including mutations in the ubiquitin E3 ligase UBR5. Approximately 18% of MCL patients were found to have mutations in UBR5, with the majority of mutations within the HECT domain of the protein that can accept and transfer ubiquitin molecules to the substrate. Determining if UBR5 controls the maturation of B cells is important to fully understand malignant transformation to MCL. To elucidate the role of UBR5 in B-cell maturation and activation, we generated a conditional mutant disrupting UBR5's C-terminal HECT domain. Loss of the UBR5 HECT domain leads to a block in maturation of B cells in the spleen and upregulation of proteins associated with messenger RNA splicing via the spliceosome. Our studies reveal a novel role of UBR5 in B-cell maturation by stabilization of spliceosome components during B-cell development and suggests UBR5 mutations play a role in MCL transformation.

来源:Blood,查看原文。版权归原作者所有。

引用

  1. Swenson SA, Gilbreath TJ, Vahle H, et al. UBR5 HECT domain mutations identified in mantle cell lymphoma control maturation of B cells. Blood. 2020. PMID: 32325489. doi:10.1182/blood.2019002102

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。